Physiology in Medicine
Roles of leukocyte/endothelial cell adhesion molecules in the pathogenesis of vasculitis

https://doi.org/10.1016/S0002-9343(99)00132-1Get rights and content

Section snippets

Leukocyte/endothelial cell adhesion molecules

Three major families of adhesion molecules have been described and include the selectins, integrins, and members of the immunoglobulin superfamily of adhesion receptors (Table 2)1, 2. These proteins mediate a wide variety of cell–cell interactions during normal immune and inflammatory responses, including leukocyte–leukocyte interactions, and leukocyte adhesion to endothelial cells, smooth muscle, extracellular matrix, and interstitial cells. A major function of these adhesion molecules is to

Adhesion molecule expression in human vasculitic diseases

There is now substantial experimental evidence that shows that adhesion molecule expression is induced or upregulated in affected tissues from patients with a wide variety of inflammatory diseases, including rheumatoid arthritis, atherosclerosis, multiple sclerosis, and diabetes 10, 11, 12. However, only a limited number of studies have investigated adhesion molecule expression in vasculitic disorders. These investigations have focused mainly in ICAM-1, VCAM-1, VLA-4, LFA-1, and Mac-1

In vitro model systems of human vasculitis

Specific mechanisms of leukocyte adhesion to endothelial monolayers have recently begun to be identified through the use of endothelial tissue culture techniques. Since the initial report by Jaffe et al (44) describing the culture of human venous endothelial cells from human umbilical veins, many studies have employed these and other types of endothelial cell cultures to understand better how the endothelium participates in immune responses and thrombotic states, and maintains its permselective

In vivo animal models of vasculitis

Although these in vitro studies have enhanced our understanding of how vasculitic lesion initiation and progression may occur, they are limited in that they cannot fully reproduce the pathophysiologic conditions that occur in vivo. Experimental animal model systems, such as the MRL/Mpj-Faslpr mice, NZB/NZW mice, and the Shwartzman and Arthus reactions have been used to elucidate the roles of adhesion molecules in the development of vasculitis (Table 3). Although these systems are valuable tools

Summary and future directions

Considerable experimental evidence has been reported to support the hypothesis that leukocyte–endothelial cell adhesion molecules are important mediators of tissue injury in a wide variety of inflammatory diseases. In comparison, the roles of adhesion molecules in the development of vasculitic diseases have only recently begun to be defined, and only a few adhesion molecules, such as ICAM-1 and VCAM-1, have been actively investigated. Comprehensive analyses that determine the expression and

First page preview

First page preview
Click to open first page preview

References (92)

  • G.S. Kansas

    Selectins and their ligandscurrent concepts and controversies

    Blood

    (1996)
  • R.S. Larson et al.

    Structure and function of leukocyte integrins

    Immunol Rev

    (1990)
  • M.V.D. Vieren et al.

    A novel leukointegrin, αdB2, binds preferentially to ICAM-3

    Immunity

    (1995)
  • D.M. Danilenko et al.

    A novel canine leukointegrin, alpha(d)beta(2), is expressed by specific macrophage subpopulations in tissue and a minor CD8(+) lymphocyte subpupulation in peripheral blood

    J Immunol

    (1995)
  • D.C. Anderson et al.

    The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiencytheir quantitative definition and relation to leukocyte dysfunction and clinical feature

    J Infect Dis

    (1985)
  • D.C. Anderson et al.

    Leukocyte adhesion deficiencyan inherited defect in the Mac-1, LFA-1 and p150,95 glycoproteins

    Ann Rev Med

    (1987)
  • D.E. Shuster et al.

    Identification and prevalence of a genetic defect that causes leukocyte adhesion deficiency in Holstein cattle

    Proc Natl Acad Sci USA

    (1992)
  • M.P. Bevilacqua et al.

    Endothelial-leukocyte adhesion molecules in human diseases

    Ann Rev Med

    (1994)
  • C.F. Mojcik et al.

    Adhesion moleculesa rheumatologic perspective

    Arthr Rheum

    (1997)
  • D.K. Ledford

    Immunologic aspects of vasculitis and cardiovascular disease

    JAMA

    (1997)
  • Cupps TR. Vasculitis: epidemiology, pathology, and pathogenesis, 11th ed. In: Wortmann R, Klippel JH, eds. Primer on...
  • G.S. Hoffman et al.

    Antineutrophil cytoplasmic antibodies

    Arthr Rheum

    (1998)
  • I.C. Locke et al.

    Autoantibodies to neutrophil granule proteinspathogenic potential in vasculitis?

    Br J Biomed Sci

    (1996)
  • M.T. Keogan et al.

    Activation of normal neutrophils by anti-neutrophil cytoplasm antibodies

    Clin Exp Immunol

    (1992)
  • N. Del Papa et al.

    Anti-endothelial cell IgG antibodies from patients with Wegener’s granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion

    Arthr Rheum

    (1996)
  • M.C. Cid

    New developments in the pathogenesis of systemic vasculitis

    Curr Op Rheum

    (1996)
  • B. Riecken et al.

    Impaired granulocyte oxidative burst and decreased expression of leukocyte adhesion molecule-1 (LAM-1) in patients with Wegener’s granulomatosis

    Clin Exp Immunol

    (1994)
  • H. Haller et al.

    Circulating leukocyte integrin expression in Wegener’s granulomatosis

    J Am Soc Nephr

    (1967)
  • J. Gutfleisch et al.

    Increased expression of CD25 and adhesion molecules on peripheral blood lymphocytes of patients with Wegener’s granulomatosis (WG) and ANCA positive vasculitides

    Adv Exp Med Biol

    (1993)
  • M.P. Rastaldi et al.

    Intraglomerular and interstitial leukocyte infiltration, adhesion molecules, and interleukin-1a expression in 15 cases of antineutrophil cytoplasmic autoantibody-associated renal vasculitis

    Am J Kid Dis

    (1995)
  • A.A. Pall et al.

    Glomerular vascular cell adhesion molecule-1 expression in renal vasculitis

    J Clin Pathol

    (1996)
  • J.C. Jennette et al.

    Nomenclature of systemic vasculitides

    Arthr Rheum

    (1994)
  • F. Schoen

    Blood vessels

  • B. Coll-Vinent et al.

    Dynamic patterns of endothelial cell adhesion molecule expression in muscle and perineural vessels from patients with classic polyarteritis nodosa

    Arthr Rheum

    (1998)
  • J.R. Bradley et al.

    Endothelial cell activation in patients with systemic vasculitis

    QJM

    (1994)
  • C. Schaufelberger et al.

    T lymphocytes in giant cell arteritic lesions are polyclonal cells expression alpha beta type antigen receptors and VLA-1 integrin receptors

    Clin Exp Immunol

    (1993)
  • S.O. Wawryk et al.

    Analysis of adhesion molecules in the immunopathogenesis of giant cell arteritis

    J Clin Path

    (1991)
  • T. Takeuchi et al.

    Upregulated expression and function of the integrin adhesive receptors in systemic lupus erythematosus patients with vasculitis

    J Clin Invest

    (1993)
  • H.M. Belmont et al.

    Upregulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosusthe Schwartzman phenomenon revisited

    Arthr Rheum

    (1994)
  • N.P. Burrows et al.

    Comparison of cell adhesion molecule expression in cutaneous leucocytoclastic and lymphocytic vasculitis

    Am J Kidney Dis

    (1994)
  • G. Sais et al.

    Adhesion molecule expression and endothelial cell activation in cutaneous leukocytoclastic vasculitis. An immunohistologic and clinical study in 42 patients

    Arch Derm

    (1997)
  • P.K. Panegyres et al.

    Endothelial cell activation in vasculitis of peripheral nerve and skeletal muscle

    J Neurol Neurosurg Psych

    (1992)
  • R.M. Flipo et al.

    ICAM-1, E-selectin, and TNFα expression in labial salivary glands of patients with rheumatoid vasculitis

    Ann Rheum Dis

    (1997)
  • J.W.C. Tervaert et al.

    Cell adhesion molecules in vasculitis

    Curr Op Rheum

    (1997)
  • S. John et al.

    Serum circulating ICAM-1 levels are not useful to indicate active vasculitis or early renal allograft rejection

    Clin Nephr

    (1994)
  • Cited by (66)

    • Recruitment of Inflammatory and Immune Cells in the Gut

      2018, Physiology of the Gastrointestinal Tract, Sixth Edition
    • Recruitment of Inflammatory and Immune Cells in the Gut: Physiology and Pathophysiology

      2012, Physiology of the Gastrointestinal Tract, Two Volume Set
    • Biomarkers of endothelial cell activation: Candidate markers for drug-induced vasculitis in patients or drug-induced vascular injury in animals

      2012, Vascular Pharmacology
      Citation Excerpt :

      Fig. 3 shows the characteristic morphological features in drug-treated rats that resemble the features in patients with AAVs. In patients, histopathology of AAVs is characterized by fibrinoid necrosis of the vessel wall, inflammatory infiltrate within and around the vessels and leukocytoclasia (nuclear fragmentation of polymorphonuclear leukocyte) (Dupuy et al., 1998; Fazzini et al., 2001; Jennette and Falk, 1997; Kevil and Bullard, 1999; Sanchez et al., 1985; ten Holder et al., 2002). The terms “EC swelling” “swollen vascular EC”, “EC hyperplasia”, and “EC proliferation” suggestive of EC activation were frequently described in patients with a variety of vasculitides, including systemic vasculitis (Bradley et al., 1994), drug-induced cutaneous vasculitis (Jain, 1993), necrotizing vasculitis (Sanchez et al., 1985), ANCA-positive cutaneous leukocytoplasmic vasculitis (Miller et al., 1998), and leukocytoplasmic vasculitis (Dupuy et al., 1998).

    • Defects of mitogen-activated protein kinase in ICOS signaling pathway lead to CD4<sup>+</sup> and CD8<sup>+</sup> T-cell dysfunction in patients with active SLE

      2009, Cellular Immunology
      Citation Excerpt :

      Recently, it has become evident that lupus T-cells, which participate in the immune pathogenesis of SLE through multiple ways, hold the central position in this disease [3]. They attack on target cells or tissues through overproduction of proinflammatory cytokines or an increase in cell-to-cell adhesion, ultimately leading to the apoptosis of the target cells [4]. On the other hand, lupus T-cells initiate autoimmune B cell precursors and generate anti-apoptosis signals for autoimmune cells through cytokines and costimulatory molecules [5].

    View all citing articles on Scopus
    View full text